HomeInsightsBoard of Directors

Piramal Pharma Ltd Board of Directors

Piramal Pharma Ltd Board of Directors

stocks purchased

₹ 6.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

246.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Board of Directors at Piramal Pharma Ltd

Name
Designation
Jairaj PurandareIndependent Director
Nandini PiramalChairperson
Neeraj BharadwajNon Executive Director
PETER DEYOUNGExecutive Director & CEO
Peter StevensonIndependent Director

Key Highlights

  • Nandini Piramal continues to serve as the Chairperson in 2024, maintaining the same position as in the previous year.
  • PETER D DEYOUNG continues to serve as the Executive Director & CEO in 2024, maintaining the same position as in the previous year.
  • Neeraj Bharadwaj joins the board as Non Executive Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
  • Jairaj Purandare continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
  • S Rama Dorai continues to serve as the Independent Director in 2024, maintaining the same position as in the previous year.
Image

Piramal Pharma Ltd

NSE: PPLPHARMA

Share Price

-

stock direction

Last updated on:

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024249.9
21 Nov 2024245.95
19 Nov 2024250.8
18 Nov 2024251.95
14 Nov 2024258.4
13 Nov 2024259.7
12 Nov 2024250.55
11 Nov 2024269.65
08 Nov 2024281.8
07 Nov 2024292.1

Company Fundamentals for Piramal Pharma Ltd

Market Cap

33,130 Cr

EPS

0.4

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

4.2

Day’s High *

253.3

Day’s Low

245.2

DTE *

0.6

ROE *

0.7

52 Week High

307.85

52 Week Low

114.45

ROCE *

6.4

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Piramal Pharma Ltd News Hub

News

Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT

Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...

Read more

24 Oct 202412:32

News

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...

Read more

15 Oct 202410:20

News

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...

Read more

30 Sep 202418:48

News

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...

Read more

17 Sep 202410:14

News

Piramal Pharma grants 48.30 lakh stock options

Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...

Read more

26 Jul 202410:05

News

Piramal Pharma Q1 net loss narrows to Rs 89 crore

Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...

Read more

26 Jul 202414:28

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

TranscriptPPT

Feb 2023

Transcript

Jan 2023

PPT

Nov 2022

Transcript

FAQs for Board of Directors of Piramal Pharma Ltd

How are members of Piramal Pharma Ltd Board of Directors selected?

Members of the Piramal Pharma Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Piramal Pharma Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Piramal Pharma Ltd Board of Directors?

Shareholders can interact with the Piramal Pharma Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Piramal Pharma Ltd Board of Directors meet?

The Piramal Pharma Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Piramal Pharma Ltd Board of Directors?

The Piramal Pharma Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Piramal Pharma Ltd?

The current Board of Directors at Piramal Pharma Ltd includes Nandini Piramal( Chairperson) ,PETER D DEYOUNG( Executive Director & CEO) ,Neeraj Bharadwaj( Non Executive Director) ,Jairaj Purandare( Independent Director) ,S Rama Dorai( Independent Director) . The full list can be found on Piramal Pharma Ltd’s official website or recent corporate filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*